Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function

Oak D Jo1, Jheralyn Martin, Andrew Bernath

  • 1Department of Research and Development, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California 91343, USA.

Insights

Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) regulates cyclin D1 and c-myc mRNA translation via internal ribosome entry site (IRES) activity. Akt-mediated phosphorylation of hnRNP A1 controls this process, impacting cell cycle progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Translation of cyclin D1 and c-myc mRNAs is regulated by internal ribosome entry site (IRES)-mediated initiation.
  • This process is influenced by reduced eIF-4F complex formation and Akt activity.

Purpose of the Study:

  • To identify the IRES trans-acting factor regulating cyclin D1 and c-myc IRES activity.
  • To elucidate the role of Akt in modulating this IRES activity.

Main Methods:

  • In vitro binding assays and reporter gene expression assays.
  • Analysis of hnRNP A1 phosphorylation and its effect on IRES activity.
  • Cellular knockdown and overexpression studies.
  • Monitoring mRNA polysome distribution.

Main Results:

  • hnRNP A1 identified as a key regulator of cyclin D1 and c-myc IRES activity, dependent on Akt status.
  • Akt phosphorylates hnRNP A1 at serine 199, inhibiting its ability to support IRES activity.
  • hnRNP A1 knockdown or inhibition of its function impairs rapamycin-stimulated IRES activity and alters mRNA polysome loading.
  • hnRNP A1 knockdown sensitizes cells to rapamycin-induced G1 arrest.

Conclusions:

  • hnRNP A1 mediates rapamycin-induced changes in cyclin D1 and c-myc IRES activity in an Akt-dependent manner.
  • Establishes a direct link between Akt signaling and the regulation of IRES activity.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...